cagrilintide with retatrutide vs for Weight Loss and Metabolic Health 🧪 RETATRUTIDE + CAGRILINTIDE STACK…

One month later, tirzepatide was approved for weight loss

We assessed vessels, as to whether they had afilled or cleared out (hollow) appearance at the stomach, and for arcade vessels on the ventral and dorsal sides in 1 cm long segments of duodenum, jejunum, ascending colon, and for 10 vessels from the proximal to distal cecum throughout the experiment

Aydin 1 , Frank Te Nijenhuis 2 , Marta Rubiera 3 , Susanne Bonekamp 4 , Ronen R Leker 5 , Satoru Tanioka 1 , Theo van Walsum 2 , Charles Majoie 6 , Wim Van Zwam 7 , Sam Payabvash 8 , Thomas Tourdias 9 , Christian Nolte 10 , Dietmar Frey 1,11 1 CLAIM - Charit Lab for Artificial Intelligence in Medicine, Charit Universittsmedizin Berlin, Germany, Berlin, Germany, 2 Biomedical Imaging Group Rotterdam, Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands, 3 Department of Neurology, Vall dHebrn University Hospital, Barcelona, Spain, 4 Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany, 5 Stroke Unit, Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel, 6 Department of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, Netherlands, 7 Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, Netherlands, 8 Department of Radiology, Columbia University, New York, United States, 9 Department of Neuroradiology, CHU Pellegrin, Bordeaux, France, 10 ent of Neurology with Experimental Neurology and Center for Stroke Research Berlin (CSB), Charit Universittsmedizin Berlin, Berlin, Germany, 11 Department of Neurosurgery, Charit Universittsmedizin Berlin, Berlin, Germany Background and Aims: Modelling of prognosis has the potential to improve treatment decisions and establish precision medicine in ischemic stroke

Semaglutide doses range from 0.25mg to 2.4mg, much lower than tirzepatide doses of 2.5mg to 15mg